No Data
Morgan Stanley Maintains Adient(ADNT.US) With Sell Rating, Maintains Target Price $19
Morgan Stanley Reaffirms Their Sell Rating on Adient (ADNT)
Adient's (NYSE:ADNT) Soft Earnings Are Actually Better Than They Appear
This Ulta Beauty Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Adient Falls to a Multi-year Low as Confidence Fades in the Auto Supplier
Express News | Adient PLC : BofA Global Research Cuts Price Objective to $24 From $30
I Am 102927471 :